Graft-versus-host disease (GVHD) represents one of the major complications of allogeneic bone marrow transplantation (BMT). Nevertheless, the occurrence of mild GVHD could be desirable in high-risk leukemic patients, due to a relapse-preventing effect known as the graft-versus-leukemia (GVL) effect. Given that different prophylactic interventions are available to prevent GVHD development, the decision problem consists in assessing both type and dosage of the drugs in order to avoid or induce GVHD, according to the specific patient's condition. The decision problem can be represented and solved by using an influence diagram. The choice of this formalism allows using new available methods for building and updating the model of the decision pr...
Peripheral blood stem cells (PBSCs) and bone marrow (BM) hematopoietic stem cells represent therapeu...
The graft-versus-leukemia (GVL) effect after allogeneic hematopoietic cell transplant (HCT) can prev...
We retrospectively analyzed the data base of the Italian Association of Pediatric Hematology/Oncolog...
Graft-versus-host disease (GVHD) represents one of the major complications of allogeneic bone marrow...
Relapse remains the major cause of mortality after hematopoietic cell transplantation (HCT) for pedi...
Graft-versus-host disease (GVHD) is a major factor contributing to mortality and morbidity after all...
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for a variety of hema...
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for a variety of hema...
Great variations exist in the prophylaxis and treatment of GVHD in children undergoing allogeneic st...
GVHD remains the major impediment to broader application of allogeneic haematopoietic SCT. It can be...
Graft-versus-host Disease (GvHD) prophylaxis after allogeneic hematopoietic stem-cell transplantatio...
Item does not contain fulltextRecommendations on indications for allogeneic haematopoietic SCT have ...
We discuss clinical strategies for the prophylaxis and treatment of both acute and chronic graft-ver...
Graft-versus-host Disease (GvHD) prophylaxis after allogeneic hematopoietic stem-cell transplantatio...
We retrospectively analyzed the data base of the Italian Association of Pediatric Hematology/Oncolog...
Peripheral blood stem cells (PBSCs) and bone marrow (BM) hematopoietic stem cells represent therapeu...
The graft-versus-leukemia (GVL) effect after allogeneic hematopoietic cell transplant (HCT) can prev...
We retrospectively analyzed the data base of the Italian Association of Pediatric Hematology/Oncolog...
Graft-versus-host disease (GVHD) represents one of the major complications of allogeneic bone marrow...
Relapse remains the major cause of mortality after hematopoietic cell transplantation (HCT) for pedi...
Graft-versus-host disease (GVHD) is a major factor contributing to mortality and morbidity after all...
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for a variety of hema...
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for a variety of hema...
Great variations exist in the prophylaxis and treatment of GVHD in children undergoing allogeneic st...
GVHD remains the major impediment to broader application of allogeneic haematopoietic SCT. It can be...
Graft-versus-host Disease (GvHD) prophylaxis after allogeneic hematopoietic stem-cell transplantatio...
Item does not contain fulltextRecommendations on indications for allogeneic haematopoietic SCT have ...
We discuss clinical strategies for the prophylaxis and treatment of both acute and chronic graft-ver...
Graft-versus-host Disease (GvHD) prophylaxis after allogeneic hematopoietic stem-cell transplantatio...
We retrospectively analyzed the data base of the Italian Association of Pediatric Hematology/Oncolog...
Peripheral blood stem cells (PBSCs) and bone marrow (BM) hematopoietic stem cells represent therapeu...
The graft-versus-leukemia (GVL) effect after allogeneic hematopoietic cell transplant (HCT) can prev...
We retrospectively analyzed the data base of the Italian Association of Pediatric Hematology/Oncolog...